Prevalence of clinically relevant drug-drug interactions in patients enrolled in NCTN clinical trials.

e18819Background: Oncology patients are at high risk of clinically relevant drug-drug interactions (DDIs) due to high rates of polypharmacy. DDIs in patients enrolled in clinical trials can adverse...